| Date | Time | Source | Headline | Symbol | Company |
| 05/07/2024 | 12:51PM | iHub Newswire | FeaturedCannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa | | |
| 09/13/2017 | 9:40AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 09/13/2017 | 9:34AM | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 09/07/2017 | 8:51AM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 08/09/2017 | 8:48AM | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 08/09/2017 | 8:21AM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 07/24/2017 | 5:21PM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 06/29/2017 | 5:00PM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 06/29/2017 | 4:52PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 06/12/2017 | 4:21PM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 06/09/2017 | 10:39AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 06/09/2017 | 10:37AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 06/09/2017 | 10:35AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 06/09/2017 | 10:35AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 06/09/2017 | 10:32AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 06/09/2017 | 10:31AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 06/06/2017 | 6:04AM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 06/02/2017 | 5:08PM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 06/01/2017 | 4:15PM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 06/01/2017 | 4:11PM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 05/30/2017 | 11:51AM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 05/26/2017 | 6:55PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 05/26/2017 | 6:47PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 05/11/2017 | 4:31PM | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 05/10/2017 | 6:06AM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 05/09/2017 | 4:49PM | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 05/08/2017 | 11:28AM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 05/03/2017 | 12:53PM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 05/01/2017 | 9:08AM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 05/01/2017 | 9:02AM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |